A High-Content Assay to Screen for Modulators of EGFR Function

  • Christophe Antczak
  • Hakim DjaballahEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1360)


Cell-based assays have the potential and advantage to identify cell-permeable modulators of kinase function, and hence provide an alternative to the conventional enzymatic activity-driven discovery approaches that rely on purified recombinant kinase catalytic domains. Here, we describe a domain-based high-content biosensor approach to study endogenous EGFR activity whereby EGF-induced receptor activation, subsequent trafficking, and internalization are imaged and quantified using time-dependent granule formation in cells. This method can readily be used to search for EGFR modulators in both chemical and RNAi screening; with potential applicability to other receptor tyrosine kinases.

Key words

RNAi siRNA Iressa Kinase Inhibitor High-content assay EGFR Cancer Drug discovery INCA2000 INCA3000 Microscopy HTS 



Work presented here was supported by Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center for MSKCC, the William Randolph Hearst Fund in Experimental Therapeutics, the Lillian S Wells Foundation, and an NIH/NCI Cancer Center Support Grant 5 P30 CA008748–44. We thank Dr. Nancy Liu-Sullivan for her help during the write-up stages of the manuscript and with the earlier versions of the assay schematic.


  1. 1.
    Pao W, Chmielecki J (2010) Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 10:760–774PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Ciaccio MF, Wagner JP, Chuu CP et al (2010) Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat Methods 7:148–155PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Olive DM (2004) Quantitative methods for the analysis of protein phosphorylation in drug development. Expert Rev Proteomics 1:327–341CrossRefPubMedGoogle Scholar
  4. 4.
    Pennucci J, Swanson S, Kaliyaperumal A et al (2010) Multiplexed evaluation of a cell-based assay for the detection of antidrug neutralizing antibodies to panitumumab in human serum using automated fluorescent microscopy. J Biomol Screen 15:644–652CrossRefPubMedGoogle Scholar
  5. 5.
    Ghosh RN, Grove L, Lapets OA (2004) Quantitative cell-based high-content screening assay for the epidermal growth factor receptor-specific activation of mitogen-activated protein kinase. Assay Drug Dev Technol 2:473–481CrossRefPubMedGoogle Scholar
  6. 6.
    Lanzerstorfer P, Borgmann D, Schutz G et al (2014) Quantification and kinetic analysis of Grb2-EGFR interaction on micro-patterned surfaces for the characterization of EGFR-modulating substances. PLoS One 9(3):e92151Google Scholar
  7. 7.
    Antczak C, Bermingham A, Calder P et al (2012) Domain-based biosensor assay to screen for epidermal growth factor receptor modulators in live cells. Assay Drug Dev Technol 10:24–36PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Sigma-Aldrich: EGFR biosensor cell line. Accessed 11 Mar 2014
  9. 9.
    Antczak C, Mahida JP, Bhinder B et al (2012) A high-content biosensor-based screen identifies cell-permeable activators and inhibitors of EGFR function: Implications in drug discovery. J Biomol Screen 17:885–899PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.HTS Core FacilityMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Center for Proteomic ChemistryNovartis Institutes for Biomedical ResearchCambridgeUSA
  3. 3.Institut Pasteur KoreaBundang-gu, Seongnam-siSouth Korea

Personalised recommendations